These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10679656)

  • 1. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade 2 oligodendroglioma.
    Reis-Filho JS; Faoro LN; Carrilho C; Bleggi-Torres LF; Schmitt FC
    Cancer; 2000 Feb; 88(4):862-9. PubMed ID: 10679656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of apoptosis in the prognosis of oligodendrogliomas.
    Schiffer D; Dutto A; Cavalla P; Chiò A; Migheli A; Piva R
    Neurochem Int; 1997 Aug; 31(2):245-50. PubMed ID: 9220457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
    Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.
    Kros JM; Hop WC; Godschalk JJ; Krishnadath KK
    Cancer; 1996 Sep; 78(5):1107-13. PubMed ID: 8780550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma.
    Deininger MH; Weller M; Streffer J; Meyermann R
    Cancer; 1999 Nov; 86(9):1832-9. PubMed ID: 10547558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
    Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
    Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas.
    Coons SW; Johnson PC; Pearl DK
    Neurosurgery; 1997 Oct; 41(4):878-84; discussion 884-5. PubMed ID: 9316050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and survival-related factors in patients with well-differentiated oligodendrogliomas.
    Maiuri F; Del Basso De Caro ML; Iaconetta G; Peca C; Esposito M; de Divitiis E
    Zentralbl Neurochir; 2006 Nov; 67(4):204-9. PubMed ID: 17106834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in oligodendroglioma.
    Schiffer D; Dutto A; Cavalla P; Bosone I; Chiò A; Villani R; Bellotti C
    Can J Neurol Sci; 1997 Nov; 24(4):313-9. PubMed ID: 9398978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation (MIB-1 expression) in oligodendrogliomas: assessment of quantitative methods and prognostic significance.
    Coleman KE; Brat DJ; Cotsonis GA; Lawson D; Cohen C
    Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):109-14. PubMed ID: 16540741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases.
    Korshunov A; Golanov A
    J Neurooncol; 2000 May; 48(1):13-9. PubMed ID: 11026692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
    Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
    J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodendroglioma: pathology and molecular biology.
    Engelhard HH; Stelea A; Cochran EJ
    Surg Neurol; 2002 Aug; 58(2):111-7; discussion 117. PubMed ID: 12453646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry of oligodendrogliomas with special reference to prognosis.
    Heegaard S; Sommer HM; Broholm H; Broendstrup O
    Cancer; 1995 Nov; 76(10):1809-13. PubMed ID: 8625052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases.
    Dehghani F; Schachenmayr W; Laun A; Korf HW
    Acta Neuropathol; 1998 May; 95(5):493-504. PubMed ID: 9600596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of TP53 mutations, p53 protein, Ki-67 index and conventional histological grading in oligodendrogliomas.
    Hagel C; Krog B; Laas R; Stavrou DK
    J Exp Clin Cancer Res; 1999 Sep; 18(3):305-9. PubMed ID: 10606174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases.
    Korshunov A; Golanov A; Sycheva R; Pronin I
    J Clin Pathol; 1999 Aug; 52(8):574-80. PubMed ID: 10645226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.
    Keshgegian AA; Cnaan A
    Am J Clin Pathol; 1995 Jul; 104(1):42-9. PubMed ID: 7611179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.